Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: The FAVOStudy

Osteoporosis International

Volumn 8, Issue 1, 1998, Pages 4-12

  Meunier, P J ^a   Sebert, J L ^b   Reginster, J Y ^c   Briancon, D ^d   Appelboom, T ^e   Netter, P ^f   Loeb, G ^g   Rouillon, A ^h   Barry, S ⁱ   Evreux, J C ^a   Avouac, B ^j   Marchandise, X ^k  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Hopital Reine Hortense   (France)

^e Division of Rheumatology Erasmus University Hospital   (Belgium)

^f CNRS   (France)

^g Yamanouchi Pharma ^*  (France)

^h Merck Clevenot Laboratories   (France)

ⁱ RCTs   (France)

^j HENRI MONDOR HOSPITAL   (France)

^k LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Calcium; Monofluorophosphate; Postmenopausal osteoporosis; Sodium fluoride; Vertebral fracture; Vitamin D

Indexed keywords

CALCIUM; FLUOCALCIC; FLUORIDE SODIUM; FLUOROPHOSPHATE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LEG PAIN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTEBRA FRACTURE;

EID: 6844250765     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050041     Document Type: Article

References (19)

1. Rich C, Ensinck J. Effect of sodium fluoride on calcium metabolism in human beings. Nature 1961;194:184-5.
2. Rigas BL, Hodgson SF, Hoffmann DL, Kelly PJ, Johnson KA, Taves D. Treatment of primary osteoporosis with fluoride and calcium: clinical tolerance and fracture occurrence. JAMA 1980;243:446-9.
3. Briançon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop Clin North Am 1981;12:629-48.
4. Kleerekoper M, Mendlovic DB, Sodium fluoride therapy of postmenopausal osteoporosis. Endocr Rev 1993;14:312-23.
5. Mamelle N, Meunier PJ, Dusan R, et al. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988;ii:361-5.
6. Riggs BL, Hodgson SF, O'Fallon WM, et al. Effect of fluoride treatment on fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802-9.
7. Kleerekoper M, Peterson EL, Nelson DA, et al. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1991;1:155-61.
8. Pak CYC, Zerwekh JE, Antich PP. Bell NH, Singer FR. Slow-release sodium fluoride in osteoporosis. J Bone Miner Res 1996;11:561-4.
9. Genant HK, Wu CY, van Kuijk C, Nevitt M. Vertebral fracture assessment using a semi-quantitative technique. J Bone Miner Res 1993;8:1137-48.
10. Genant HK, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incidental vertebral fractures in osteoporosis. J Bone Miner Res 1996;11:984-96.
11. Recker RR, Hinders S, Davies KM, et al. Correcting calcium nutritional deficeincy prevents spine fractures in elderly women. J Bone Miner Res 1996;11:1961-6.
12. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier PJ. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 1996;3:1129-33.
13. Chapuy MC, Preziosi P, Maarner M, et al. Prevalence of hypovitaminosis D in the adult normal population. Osteoporos Int 1997; in press.
14. Lundy MW, Stauffer M, Wergedal JE, et al. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects. Osteoporos Int 1995;5:2-17.
15. Aaron JE, de Vernejoul MC, Kanis JA. The effect of sodium fluoride on trabecular architecture in osteoporosis. Bone 1991;12:307-10.
16. Reginster JY,Zegels B, Meurmans L, et al. Monofluorophosphate decreases vertebral fracture rate in postmenopausal osteoporosis: a randomised placebo-controlled, double blind study [abstract]. Osteoporos Int 1996;6(Suppl 1):239.
17. Turner CH. Fluoride and the FDA: a curious case. J Bone Miner Res 1996;11:1369-70.
18. Kleerekoper M. Fluoride: the verdict is in, but the controversy lingers. J Bone Miner Res 1996;11:565-7.
19. Zerwekh JE, Hagler HK, Sakhaee K, Gottschalk F, Peterson RD, Pak CYC. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis. Bone 1994;15:691-9.